QS Investors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $965K | Sell |
6,175
-5
| -0.1% | -$810 | 0.01% | 507 |
|
|
2021
Q1 | $961K | Sell |
6,180
-745
| -11% | -$115K | 0.01% | 547 |
|
|
2020
Q4 | $1.04M | Buy |
6,925
+476
| +7% | +$67.2K | 0.01% | 494 |
|
|
2020
Q3 | $853K | Sell |
6,449
-928
| -13% | -$121K | 0.01% | 490 |
|
|
2020
Q2 | $855K | Sell |
7,377
-821
| -10% | -$94.6K | 0.01% | 766 |
|
|
2020
Q1 | $805K | Hold |
8,198
| – | – | 0.01% | 725 |
|
|
2019
Q4 | $1.19M | Sell |
8,198
-351
| -4% | -$48.5K | 0.01% | 737 |
|
|
2019
Q3 | $1.14M | Sell |
8,549
-515
| -6% | -$66.5K | 0.01% | 747 |
|
|
2019
Q2 | $1.04M | Hold |
9,064
| – | – | 0.01% | 784 |
|
|
2019
Q1 | $1.12M | Sell |
9,064
-11
| -0.1% | -$1.25K | 0.01% | 781 |
|
|
2018
Q4 | $914K | Sell |
9,075
-9
| -0.1% | -$1.01K | 0.01% | 786 |
|
|
2018
Q3 | $1.16M | Sell |
9,084
-368
| -4% | -$43.8K | 0.01% | 775 |
|
|
2018
Q2 | $1.02M | Buy |
9,452
+10
| +0.1% | +$1.09K | 0.01% | 788 |
|
|
2018
Q1 | $1M | Hold |
9,442
| – | – | 0.01% | 781 |
|
|
2017
Q4 | $1.11M | Sell |
9,442
-164
| -2% | -$18.5K | 0.01% | 777 |
|
|
2017
Q3 | $1.09M | Hold |
9,606
| – | – | 0.01% | 789 |
|
|
2017
Q2 | $1.2M | Buy |
9,606
+824
| +9% | +$97.7K | 0.01% | 730 |
|
|
2017
Q1 | $1.04M | Buy |
8,782
+5,768
| +191% | +$654K | 0.01% | 790 |
|
|
2016
Q4 | $302K | Hold |
3,014
| – | – | ﹤0.01% | 1021 |
|
|
2016
Q3 | $380K | Buy |
3,014
+381
| +14% | +$47.1K | ﹤0.01% | 953 |
|
|
2016
Q2 | $308K | Buy |
2,633
+2
| +0.1% | +$226 | ﹤0.01% | 1017 |
|
|
2016
Q1 | $272K | Sell |
2,631
-223
| -8% | -$21.6K | ﹤0.01% | 1019 |
|
|
2015
Q4 | $284K | Buy |
2,854
+14
| +0.5% | +$1.37K | ﹤0.01% | 1022 |
|
|
2015
Q3 | $259K | Sell |
2,840
-908
| -24% | -$91K | ﹤0.01% | 1020 |
|
|
2015
Q2 | $397K | Sell |
3,748
-1,384
| -27% | -$153K | ﹤0.01% | 927 |
|
|
2015
Q1 | $586K | Hold |
5,132
| – | – | 0.01% | 849 |
|
|
2014
Q4 | $566K | Sell |
5,132
-590
| -10% | -$62.2K | 0.01% | 840 |
|
|
2014
Q3 | $559K | Sell |
5,722
-1,133
| -17% | -$111K | 0.02% | 433 |
|
|
2014
Q2 | $691K | Sell |
6,855
-629
| -8% | -$61.4K | 0.02% | 430 |
|
|
2014
Q1 | $688K | Buy |
7,484
+721
| +11% | +$66.5K | 0.02% | 410 |
|
|
2013
Q4 | $612K | Sell |
6,763
-1,978
| -23% | -$171K | 0.02% | 400 |
|
|
2013
Q3 | $696K | Sell |
8,741
-3,022
| -26% | -$238K | 0.03% | 388 |
|
|
2013
Q2 | $877K | Buy |
+11,763
| New | +$880K | 0.03% | 417 |
|
Other funds holding ZBH
N
QS Investors's ZBH Position: Q2 2021 in Review
QS Investors reduced its Zimmer Biomet (ZBH) stake by 0.08% in Q2 2021, selling an estimated $810 and leaving 6,175 shares worth $965K. The position accounts for 0.01% of the portfolio, ranked #507.
QS Investors first reported a position in ZBH in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.2M in Q2 2017. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.
- QS Investors held 6,175 shares of Zimmer Biomet worth $965K as of Q2 2021.
- QS Investors sold 5 Zimmer Biomet shares in Q2 2021, an estimated $810.
- Zimmer Biomet made up 0.01% of QS Investors's portfolio in Q2 2021, its #507 holding.
- QS Investors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Zimmer Biomet position peaked at $1.2M in Q2 2017.
- 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.